10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001410578-23-002169`
Period End Date	20230930
Filing Date	20231102
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	cldx-20230930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 73 Cash Flow Statement 55

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.43M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.13M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$214.21M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$275.52M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$252.00K	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$347.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.33M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$245.93M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$317.69M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.26M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.20M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.26M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.75M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.16M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.20M	shares	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$4.00M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.86M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$107.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$104.00K	USD	Point-in-time
Total assets	`Assets`	$352.74M	USD	Point-in-time
Total assets	`Assets`	$280.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.34M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.59M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$18.47M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.84M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.45M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.55M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$4.23M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$990.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.61M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.30M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.59M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.53M	USD	Point-in-time
Total liabilities	`Liabilities`	$33.54M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 47,264,197 and 47,200,695 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 47,264,197 and 47,200,695 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.58B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.60B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.13M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.35B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.26B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$277.54M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$345.42M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$326.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$302.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$419.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$246.72M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$365.09M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$398.10M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$280.26M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$352.74M	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.75M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$744.00K	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.52M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$407.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$59.36M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$21.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$34.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$87.58M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$22.08M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.53M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$20.60M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.22M	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	3 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$6.86M	USD	3 Qtrs
Litigation settlement related loss	`GainLossRelatedToLitigationSettlement`	$-15.00M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$28.10M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$42.76M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$88.09M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$109.67M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-106.92M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-41.24M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-27.70M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-87.35M	USD	3 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$1.51M	USD	3 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$8.79M	USD	3 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$2.98M	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$912.00K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-98.12M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-85.84M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.50M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-38.26M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.78M	USD	1 Quarter
Basic net loss per common share	`EarningsPerShareBasic`	$-1.83	USD	3 Qtrs
Basic net loss per common share	`EarningsPerShareBasic`	$-0.81	USD	1 Quarter
Basic net loss per common share	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Basic net loss per common share	`EarningsPerShareBasic`	$-2.08	USD	3 Qtrs
Diluted net loss per common share	`EarningsPerShareDiluted`	$-2.08	USD	3 Qtrs
Diluted net loss per common share	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Diluted net loss per common share	`EarningsPerShareDiluted`	$-0.81	USD	1 Quarter
Diluted net loss per common share	`EarningsPerShareDiluted`	$-1.83	USD	3 Qtrs
Shares used in calculating basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	47,261.00	shares	1 Quarter
Shares used in calculating basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	47,243.00	shares	3 Qtrs
Shares used in calculating basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	46,916.00	shares	1 Quarter
Shares used in calculating basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	46,806.00	shares	3 Qtrs
Shares used in calculating diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46,806.00	shares	3 Qtrs
Shares used in calculating diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	47,261.00	shares	1 Quarter
Shares used in calculating diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	47,243.00	shares	3 Qtrs
Shares used in calculating diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46,916.00	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-98.12M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-85.84M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.50M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-38.26M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.78M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$63.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$305.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-529.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.78M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-51.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$863.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$875.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.01M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-38.20M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-87.84M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-97.25M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-26.48M	USD	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-98.12M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-85.84M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.50M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-38.26M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.78M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.22M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.25M	USD	3 Qtrs
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$4.04M	USD	3 Qtrs
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.37M	USD	3 Qtrs
Loss on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	3 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	3 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$6.86M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$11.10M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$16.68M	USD	3 Qtrs
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-95.00K	USD	3 Qtrs
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$17.00K	USD	3 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.76M	USD	3 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.93M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.51M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$720.00K	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.26M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.12M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-81.97M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-74.76M	USD	3 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$192.87M	USD	3 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$249.70M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$132.61M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$183.17M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.59M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.15M	USD	3 Qtrs
Proceeds from sale or disposal of assets	`ProceedsFromSaleOfProductiveAssets`	$69.00K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$58.73M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$65.38M	USD	3 Qtrs
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$2.68M	USD	3 Qtrs
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$1.08M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.08M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.68M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-20.56M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-8.29M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.13M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.43M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.13M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.43M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.58M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$488.00K	USD	3 Qtrs
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$38.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.